Infectious Disease and Microbiology – Enterobacter Species

Overview

Enterobacter species are aerobic Gram-negative bacilli belonging to the Enterobacterales. They normally colonize the gastrointestinal tract but are important opportunistic and healthcare-associated pathogens.

Major infections include urinary tract infection, pneumonia, catheter-associated bacteremia, surgical-site infection, and neonatal meningitis.

Important Species

Species traditionally included in this group include:

• Enterobacter cloacae

• Enterobacter aerogenes

• Enterobacter sakazakii

• Enterobacter tayorae

• Other Enterobacter species

Some older names in this list have subsequently undergone taxonomic reclassification, but they may still appear in older microbiology references.

Microbiologic Characteristics

Enterobacter species are:

• Gram-negative bacilli

• Aerobic/facultatively anaerobic organisms

• Members of the Enterobacterales

• Common colonizers of the gastrointestinal tract

Their ability to acquire and express multiple mechanisms of antimicrobial resistance makes them important hospital pathogens.

Incubation Period

The incubation period is:

Unknown or not clearly defined

Because many infections arise from the patient’s own colonizing flora, a conventional exposure-to-disease incubation period is often difficult to establish.

Epidemiology

Enterobacter species may form part of the normal enteric flora.

Many infections are endogenous, meaning that the infecting strain originates from organisms that have already colonized the patient’s gastrointestinal tract.

Nosocomial Transmission

Enterobacter species are particularly important causes of healthcare-associated infections.

Hospital outbreaks have demonstrated that transmission may also occur through:

• Person-to-person spread

• Contaminated medical equipment or materials

• Common contaminated sources

• Contaminated intravenous solutions

Thus, infection is not always derived exclusively from the patient’s own intestinal flora.

Risk Factors

Infection is especially associated with patients who are:

• Hospitalized

• Critically ill

• Immunocompromised

• Receiving broad-spectrum antibiotics

• Using urinary or vascular catheters

• Mechanically ventilated

• Recently undergoing surgery

Urinary Tract Infection

Enterobacter species can cause healthcare-associated urinary tract infections, particularly in patients with urinary instrumentation or indwelling catheters.

Manifestations range from cystitis to complicated urinary infection and urosepsis.

Pulmonary Infection

These organisms can cause hospital-acquired pneumonia, particularly in critically ill or mechanically ventilated patients.

Pulmonary infection may progress to bacteremia and sepsis in severe cases.

Catheter-Associated Bacteremia

Enterobacter species are important causes of catheter-associated bloodstream infection.

An intravascular catheter may become colonized and serve as a persistent source of bacteremia.

Management may therefore require both appropriate antimicrobial therapy and evaluation for catheter removal.

Contaminated Intravenous Infusions

Hospital outbreaks have occasionally resulted from contaminated intravenous solutions or infusions.

This can expose multiple patients to the same organism and produce clusters of bloodstream infections.

Surgical Wound Infection

Enterobacter species may infect surgical wounds, particularly in hospitalized patients with prolonged healthcare exposure or prior antimicrobial treatment.

Such infections may be polymicrobial.

Neonatal Meningitis

Some organisms historically classified within this group have been associated with neonatal meningitis.

A particularly important organism in older terminology is Enterobacter sakazakii, now classified as Cronobacter sakazakii.

Cronobacter is especially associated with severe infections in neonates, including meningitis and sepsis.

Diagnosis

Diagnosis is established by culture of the pathogen from an appropriate clinical specimen.

Depending on the infection, specimens may include:

• Blood

• Urine

• Respiratory secretions

• Cerebrospinal fluid

• Surgical wound material

• Catheter-associated specimens

Antimicrobial susceptibility testing is especially important because resistance patterns can be complex.

Antimicrobial Resistance

A major clinical feature of several Enterobacter species, particularly the Enterobacter cloacae complex, is the potential for clinically significant AmpC β-lactamase production.

AmpC can confer resistance to multiple β-lactam antibiotics and may complicate treatment.

Resistance may emerge during therapy with certain cephalosporins even when the initial laboratory isolate appears susceptible.

Treatment

The source lists several treatment options, including:

• Carbapenems, such as imipenem or meropenem

• Piperacillin–tazobactam

• Fluoroquinolones

However, because antimicrobial resistance varies considerably, treatment of serious Enterobacter infection should be based on the species, infection site, severity, and susceptibility results.

Additional Treatment Options

The source also lists:

• Third-generation cephalosporins

• Aztreonam

• Aminoglycosides

However, the possibility of AmpC-mediated resistance is particularly important when considering some β-lactams for serious Enterobacter infections.

Therefore, older treatment lists should not be interpreted as universally appropriate empiric choices.

Source Control

Management of invasive infection may require source control in addition to antibiotics.

Examples include:

• Removal of an infected vascular catheter

• Drainage of an abscess

• Management of an infected surgical site

• Removal or replacement of contaminated devices when appropriate

High-Yield Clinical Pattern

Hospitalized or critically ill patient

• ●

Urinary catheter, central line, mechanical ventilation, or recent surgery

• ●

Gram-negative bacillus causing UTI, pneumonia, or bacteremia

• ●

Potential AmpC β-lactamase-mediated resistance

→ Think Enterobacter species

Important Taxonomy Pearl

Older microbiology references may use:

Enterobacter aerogenes → now Klebsiella aerogenes

Enterobacter sakazakii → now Cronobacter sakazakii

Recognizing these older names can be useful when reviewing historical infectious-disease literature.

Exam Essentials

Genus: Enterobacter

Type: Gram-negative bacillus

Normal habitat: Gastrointestinal flora

Major setting: Nosocomial/healthcare-associated infection

Transmission: Endogenous flora, person-to-person spread, or contaminated common sources

Major infections: UTI, pneumonia, bacteremia, surgical-site infection

Important device association: Intravascular and urinary catheters

Diagnosis: Culture + antimicrobial susceptibility testing

Important resistance mechanism: AmpC β-lactamase in clinically important species such as the E. cloacae complex

Treatment: Susceptibility-guided antimicrobial therapy; serious resistant infections may require agents such as carbapenems

Older name: E. aerogenes → Klebsiella aerogenes

Older name: E. sakazakii → Cronobacter sakazakii

Key clinical pearl: Enterobacter species are important hospital-acquired Gram-negative pathogens, and the major treatment consideration is their potential for AmpC-mediated β-lactam resistance, making culture and susceptibility testing essential when selecting therapy for serious infection.